You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rubraca

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Salt Lake City (Rucaparib)

Active, not recruiting
  • Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 23, 2022

Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
  • +1 more
Nov 22, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Uterine Carcinosarcoma
  • New York, New York
  • +2 more
Apr 4, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Solid Tumor, Unspecified, Adult Trial in San Francisco (Rucaparib, Irinotecan)

Completed
  • Solid Tumor, Unspecified, Adult
  • San Francisco, California
    University of California San Francisco
Mar 2, 2021

Tumors Trial in Poland, Slovakia, United Kingdom (Rucaparib camsylate)

Completed
  • Neoplasms
  • Rucaparib camsylate
  • Biała Podlaska, Poland
  • +5 more
Oct 26, 2021

Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

Recruiting
  • Esophagus Cancer, Adenocarcinoma
  • Stomach Cancer, Adenocarcinoma
  • Chicago, Illinois
  • +7 more
Jan 31, 2022

Prostate Cancer, Endometrial Cancer Trial in Chicago (Rucaparib, Nivolumab)

Terminated
Has Results
  • Prostate Cancer
  • Endometrial Cancer
  • Chicago, Illinois
    University of Chicago Medical Center
Feb 15, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)

Enrolling by invitation
  • Metastatic Castration-Resistant Prostate Cancer
  • +5 more
  • Lakewood, Colorado
  • +37 more
Jan 18, 2022

Solid Tumor Trial in Budapest (C-14 labeled Rucaparib, Rucaparib)

Completed
  • Solid Tumor
  • Budapest, Rottenbiller Utca 13, Hungary
    PRA Magyarország Kft.
Dec 10, 2019

Tumors Trial in Kajetany, Poznan, Szczecin (Caffeine, Warfarin, Omeprazole)

Completed
  • Neoplasms
  • Kajetany, Mokra 7, Poland
  • +2 more
Jan 6, 2020

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +3 more
  • Denver, Colorado
  • +76 more
Feb 20, 2022

Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer Trial in Worldwide (Rucaparib, Nivolumab, Placebo Oral

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +6 more
  • Phoenix, Arizona
  • +238 more
Nov 3, 2021